IQVIA HOLDINGS INC. Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax
IQVIA HOLDINGS INC. (IQV) reported Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax of -$1.00 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-19.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax · last filed 2019-02-19
- IQVIA HOLDINGS INC. other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for the quarter ending 2018-12-31 was -$1.00M.
- IQVIA HOLDINGS INC. other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for the quarter ending 2018-09-30 was $1.00M.
- IQVIA HOLDINGS INC. other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for the quarter ending 2018-06-30 was $0.00.
- IQVIA HOLDINGS INC. other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for the quarter ending 2018-03-31 was -$1.00M.
- IQVIA HOLDINGS INC. other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for fiscal 2018 was -$1.00M.
- IQVIA HOLDINGS INC. other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for fiscal 2016 was -$7.00M.
- IQVIA HOLDINGS INC. other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for fiscal 2015 was -$6.00M.
- IQVIA HOLDINGS INC. other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for fiscal 2014 was -$4.00M.
| Period end | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 3 month | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 3 month as first filed | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 6 month | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 6 month as first filed | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 9 month | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 9 month as first filed | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 12 month | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | -$1.00M derived: 10-K 12 month − 3 quarters · filed 2019-02-19 | $0.00 derived: sum of 2 quarters · filed 2019-02-19 | $0.00 derived: sum of 3 quarters · filed 2019-02-19 | -$1.00M 10-K · filed 2019-02-19 | ||||
| 2018-09-30 | $1.00M 10-Q · filed 2018-10-25 | $1.00M derived: sum of 2 quarters · filed 2018-10-25 | $0.00 derived: sum of 3 quarters · filed 2018-10-25 | |||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | -$1.00M 10-Q · filed 2018-07-27 | ||||||
| 2018-03-31 | -$1.00M 10-Q · filed 2018-05-04 | |||||||
| 2017-03-31 | $0.00 10-Q · filed 2017-05-08 | -$3.00M derived: sum of 2 quarters · filed 2019-02-19 | -$5.00M derived: sum of 3 quarters · filed 2019-02-19 | -$5.65M derived: sum of 4 quarters · filed 2019-02-19 | ||||
| 2016-12-31 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | -$5.00M derived: sum of 2 quarters · filed 2019-02-19 | -$5.65M derived: sum of 3 quarters · filed 2019-02-19 | -$7.00M 10-K · filed 2019-02-19 | ||||
| 2016-09-30 | -$2.00M 10-Q · filed 2017-10-27 | -$1.71M 10-Q · filed 2016-11-03 | -$2.65M derived: sum of 2 quarters · filed 2017-10-27 | -$4.00M 10-Q · filed 2017-10-27 | -$4.14M 10-Q · filed 2016-11-03 | -$6.03M derived: sum of 4 quarters · filed 2018-02-16 | ||
| 2016-06-30 | -$650.00K 10-Q · filed 2016-07-27 | -$2.00M 10-Q · filed 2017-08-04 | -$2.43M 10-Q · filed 2016-07-27 | -$4.03M derived: sum of 3 quarters · filed 2018-02-16 | -$5.40M derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2016-03-31 | -$2.00M 10-Q · filed 2017-05-08 | -$1.78M 10-Q · filed 2016-05-03 | -$3.38M derived: sum of 2 quarters · filed 2018-02-16 | -$4.75M derived: sum of 3 quarters · filed 2018-02-16 | -$6.34M derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2015-12-31 | -$1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$2.75M derived: sum of 2 quarters · filed 2018-02-16 | -$4.34M derived: sum of 3 quarters · filed 2018-02-16 | -$6.00M 10-K · filed 2018-02-16 | -$5.83M 10-K · filed 2016-02-11 | |||
| 2015-09-30 | -$1.38M 10-Q · filed 2016-11-03 | -$2.97M derived: sum of 2 quarters · filed 2016-11-03 | -$4.62M 10-Q · filed 2016-11-03 | -$6.01M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-06-30 | -$1.59M 10-Q · filed 2016-07-27 | -$3.25M 10-Q · filed 2016-07-27 | -$4.63M derived: sum of 3 quarters · filed 2017-02-16 | -$5.72M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-03-31 | -$1.66M 10-Q · filed 2016-05-03 | $1.66M 10-Q · filed 2015-04-29 | -$3.04M derived: sum of 2 quarters · filed 2017-02-16 | -$4.13M derived: sum of 3 quarters · filed 2017-02-16 | -$4.86M derived: sum of 4 quarters · filed 2017-02-16 | |||
| 2014-12-31 | -$1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | -$2.47M derived: sum of 2 quarters · filed 2017-02-16 | -$3.21M derived: sum of 3 quarters · filed 2017-02-16 | -$4.00M 10-K · filed 2017-02-16 | -$4.02M 10-K · filed 2015-02-12 | |||
| 2014-09-30 | -$1.09M 10-Q · filed 2015-10-28 | -$1.82M derived: sum of 2 quarters · filed 2015-10-28 | -$2.62M 10-Q · filed 2015-10-28 | -$2.05M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-06-30 | -$736.00K 10-Q · filed 2015-07-29 | -$1.53M 10-Q · filed 2015-07-29 | -$960.00K derived: sum of 3 quarters · filed 2016-02-11 | -$2.25M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-03-31 | $794.00K 10-Q · filed 2015-04-29 | -$794.00K 10-Q · filed 2014-05-01 | -$224.00K derived: sum of 2 quarters · filed 2016-02-11 | -$1.51M derived: sum of 3 quarters · filed 2016-02-11 | -$2.83M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2013-12-31 | -$1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | -$2.30M derived: sum of 2 quarters · filed 2016-02-11 | -$3.62M derived: sum of 3 quarters · filed 2016-02-11 | -$4.99M 10-K · filed 2016-02-11 | $4.99M 10-K · filed 2014-02-13 | |||
| 2013-09-30 | -$1.28M 10-Q · filed 2014-10-30 | -$2.60M derived: sum of 2 quarters · filed 2014-10-30 | -$3.97M 10-Q · filed 2014-10-30 | -$5.09M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-06-30 | -$1.32M 10-Q · filed 2014-07-31 | $98.00K 10-Q · filed 2013-08-01 | -$2.69M 10-Q · filed 2014-07-31 | $108.00K 10-Q · filed 2013-08-01 | -$3.81M derived: sum of 3 quarters · filed 2015-02-12 | -$3.79M derived: sum of 4 quarters · filed 2015-02-12 | ||
| 2013-03-31 | -$1.37M 10-Q · filed 2014-05-01 | -$2.49M derived: sum of 2 quarters · filed 2015-02-12 | -$2.47M derived: sum of 3 quarters · filed 2015-02-12 | -$2.64M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2012-12-31 | -$1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | -$1.11M derived: sum of 2 quarters · filed 2015-02-12 | -$1.27M derived: sum of 3 quarters · filed 2015-02-12 | -$1.31M 10-K · filed 2015-02-12 | $1.31M 10-K · filed 2014-02-13 | |||
| 2012-09-30 | $13.00K 10-Q · filed 2013-10-31 | -$156.00K derived: sum of 2 quarters · filed 2013-10-31 | -$194.00K 10-Q · filed 2013-10-31 | |||||
| 2012-06-30 | -$169.00K 10-Q · filed 2013-08-01 | -$379.00K 10-Q · filed 2013-08-01 | ||||||
| 2011-12-31 | $5.54M 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |